UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 384

Sortiert nach

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature

Cancer research (Chicago, Ill.), 1997-05, Vol.57 (10), p.1829-1834

1997

Link zum Volltext

Verfügbarkeit prüfen

Differentiation and Definition of Vascular-Targeted Therapies

Clinical cancer research, 2005-01, Vol.11 (2), p.416-420

2005

Link zum Volltext

Verfügbarkeit prüfen

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

Clinical cancer research, 2005-01, Vol.11 (2), p.690-696

2005

Link zum Volltext

Verfügbarkeit prüfen

A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer

Gynecologic oncology, 2017-11, Vol.147 (2), p.276-282

2017

Link zum Volltext

Verfügbarkeit prüfen

Lymph node status as a prognostic indicator after preoperative neoadjuvant chemoradiotherapy of rectal cancer

Colorectal disease, 2014-10, Vol.16 (10), p.O339-O346

2014

Link zum Volltext

Verfügbarkeit prüfen

Surveillance policy for stage I ovarian germ cell tumors

Journal of clinical oncology, 1997-02, Vol.15 (2), p.620-624

1997

Link zum Volltext

Verfügbarkeit prüfen

Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment

Annals of oncology, 2018-10, Vol.29, p.viii336-viii336

2018

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Two Intravenous Schedules of the Topoisomerase I Inhibitor Liposomal Lurtotecan in Women With Relapsed Epithelial Ovarian Cancer: A Trial of the National Cancer Institute of Canada Clinical Trials Group

Journal of clinical oncology, 2005-03, Vol.23 (9), p.1859-1866

2005

Link zum Volltext

Verfügbarkeit prüfen

A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)

Annals of oncology, 2006-07, Vol.17 (7), p.1111-1119

2006

Link zum Volltext

Verfügbarkeit prüfen

Using e-learning as a tool for multidisciplinary education

European journal of cancer care, 2007-01, Vol.16 (1), p.90-93

2007

Link zum Volltext

Verfügbarkeit prüfen

Impact of a 2-Week Oncology Placement on Medical Students’ Perception of Cancer

Journal of cancer education, 2018-02, Vol.33 (1), p.174-179

2018

Link zum Volltext

Verfügbarkeit prüfen

Deconstructing the construction of a learning module on practice development

European journal of cancer care, 2007-03, Vol.16 (2), p.201-205

2007

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours

Cancer chemotherapy and pharmacology, 2007-08, Vol.60 (3), p.407-413

2007

Link zum Volltext

Verfügbarkeit prüfen

Practice development - Part 2: evaluating a practice initiative

European journal of cancer care, 2007-05, Vol.16 (3), p.208-208

2007

Link zum Volltext

Verfügbarkeit prüfen

Practice development - Part 1: developing a practice initiative in oncology and palliative care

European journal of cancer care, 2007-03, Vol.16 (2), p.100-100

2007

Link zum Volltext

Verfügbarkeit prüfen

How Do Patients Aged 85 and Older Fare with Abdominal Surgery?

Journal of the American Geriatrics Society (JAGS), 2010-01, Vol.58 (1), p.104-108

2010

Link zum Volltext

Verfügbarkeit prüfen

8056 ORAL Developing a web-based multidisciplinary cancer education forum

European journal of cancer supplements, 2007, Vol.5 (4), p.427-427

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of NKTR-102 in women with platinum-resistant/refractory ovarian cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5013-5013

2010

Link zum Volltext

Verfügbarkeit prüfen

Addressing the burden of cancer in East Africa through cascaded training and education by local doctors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.11000-11000

2018

Link zum Volltext

Verfügbarkeit prüfen

The role of NKTR-102 in women with platinum resistant/refractory ovarian cancer and failure on pegylated liposomal doxorubicin (PLD)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5047-5047

2011

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in mesothelioma

Clinical medicine (London, England), 2003-07, Vol.3 (4), p.314-317

Dark, Graham

2003

Link zum Volltext

Verfügbarkeit prüfen

Local Nitric Oxide Synthase Inhibition Reduces Skeletal Muscle Glucose Uptake but Not Capillary Blood Flow During In Situ Muscle Contraction in Rats

Diabetes (New York, N.Y.), 2007-12, Vol.56 (12), p.2885-2892

2007

Link zum Volltext

Verfügbarkeit prüfen

193 Vinflunine (VFL) in first line treatment of malignant pleural mesothelioma (MPM): Final results of a European phase II study

Lung cancer (Amsterdam, Netherlands), 2006-10, Vol.54, p.S47-S47

2006

Link zum Volltext

Verfügbarkeit prüfen

Open-label study of pemetrexed alone for chemonaive patients and pre-treated patients with malignant pleural mesothelioma: Outcomes of the International Expanded Access Program (EAP)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.7709-7709

2007

Link zum Volltext

Verfügbarkeit prüfen

Multicentre trial of carboplatin/paclitaxel versus oxaliplatin/capecitabine, each with/without bevacizumab, as first line chemotherapy for patients with mucinous epithelial ovarian cancer (mEOC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.5528-5528

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 384

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(331)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(263)
Life Sciences & Biomedicine
(214)
Humans
(168)
Male
(111)
Female
(110)
Biological And Medical Sciences
(95)
Medical Sciences
(78)
Adult
(66)
Middle Aged
(64)
Surgery
(60)
General & Internal Medicine
(47)
Animals
(44)
Respiratory System
(42)
Aged
(38)
Physical Sciences
(37)
Medicin Och Hälsovetenskap
(36)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(36)
Patients
(32)
Cardiac & Cardiovascular Systems
(31)
Cardiovascular System & Cardiology
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature

Differentiation and Definition of Vascular-Targeted Therapies

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer

Lymph node status as a prognostic indicator after preoperative neoadjuvant chemoradiotherapy of rectal cancer

Surveillance policy for stage I ovarian germ cell tumors

Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment

Randomized Trial of Two Intravenous Schedules of the Topoisomerase I Inhibitor Liposomal Lurtotecan in Women With Relapsed Epithelial Ovarian Cancer: A Trial of the National Cancer Institute of Canada Clinical Trials Group

A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)

Using e-learning as a tool for multidisciplinary education

Impact of a 2-Week Oncology Placement on Medical Students’ Perception of Cancer

Deconstructing the construction of a learning module on practice development

Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours

Practice development - Part 2: evaluating a practice initiative

Practice development - Part 1: developing a practice initiative in oncology and palliative care

How Do Patients Aged 85 and Older Fare with Abdominal Surgery?

8056 ORAL Developing a web-based multidisciplinary cancer education forum

Phase II study of NKTR-102 in women with platinum-resistant/refractory ovarian cancer

Addressing the burden of cancer in East Africa through cascaded training and education by local doctors

The role of NKTR-102 in women with platinum resistant/refractory ovarian cancer and failure on pegylated liposomal doxorubicin (PLD)

Recent advances in mesothelioma

Local Nitric Oxide Synthase Inhibition Reduces Skeletal Muscle Glucose Uptake but Not Capillary Blood Flow During In Situ Muscle Contraction in Rats

193 Vinflunine (VFL) in first line treatment of malignant pleural mesothelioma (MPM): Final results of a European phase II study

Open-label study of pemetrexed alone for chemonaive patients and pre-treated patients with malignant pleural mesothelioma: Outcomes of the International Expanded Access Program (EAP)

Multicentre trial of carboplatin/paclitaxel versus oxaliplatin/capecitabine, each with/without bevacizumab, as first line chemotherapy for patients with mucinous epithelial ovarian cancer (mEOC)

Suchergebnisse filtern